A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study With Follow-Up Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555-18) 1 Mg Bid For Smoking Cessation (Protocol A3051080)
A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study With Follow-Up Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555-18) 1 Mg Bid For Smoking Cessation (Protocol A3051080)
The primary objective of this protocol is to evaluate 12 weeks of treatment of varenicline compared to placebo for smoking cessation. Abstinence from cigarette smoking and other tobacco products (e.g., pipe, cigars, chew, snuff.) use during non-treatment follow-up period will also be evaluated.
Inclusion Criteria:
Exclusion Criteria:
Beirut Lebanon, Lebanon 00000, Lebanon
Tygerberg, Cape Town 7505, South Africa
Sydenham, Durban, KwaZulu-Natal 4091, South Africa
Paarl, Cape Town, Western Cape 7647, South Africa
Jumeirah/Dubai, 0, United Arab Emirates
Ras Al Khaima, 0, United Arab Emirates
Gran Caracas, Miranda 1060, Venezuela